The workshop will explore the regulatory challenges of personalised medicine from a transnational perspective, as part of the ESRC project State strategies of governance in global biomedical innovation; the impact of China and India. The focus will be on two critical issues: the challenges associated with rapid technological advances in next generation sequencing, and the changing regulatory status of laboratory-developed tests. The workshop will bring together a variety of experts from government (US FDA, UK MHRA, UK NICE, EU EMA), industry (Illumina, Janssen Diagnostics, NIBSC-UKSCB) and academia (KCL, INCa-France, UCSF-USA) from Europe, North America, India and China.
Invitation only. Email Saheli Datta (email@example.com) to register interest.